{"slideshow_credits": null, "snippet": "An ambitious clinical trial shows promise in protecting children against the disease.", "abstract": "Editorial notes ambitious clinical trial of malaria vaccine developed by GlaxoSmithKline may be significant advance in the long struggle to control the disease; says trial was in part funded with help from the Bill and Melinda Gates Foundation; expresses hope the vaccine surmounts remaining scientific and practical hurdles as it is the only broadly tested vaccine on horizon.", "section_name": "Opinion", "print_page": "24", "document_type": "article", "byline": {"person": [], "organization": "THE EDITORIAL BOARD", "original": "By THE EDITORIAL BOARD", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/10/14/opinion/hope-for-a-malaria-vaccine.html", "lead_paragraph": "An ambitious clinical trial shows promise in protecting children against the disease.", "headline": {"main": "Hope for a Malaria Vaccine", "print_headline": "Hope for a Malaria Vaccine", "content_kicker": "Editorial", "kicker": "Editorial"}, "_id": "525b450b38f0d819897420d5", "word_count": "399", "multimedia": [], "pub_date": "2013-10-14T00:00:00Z", "source": "The New York Times", "news_desk": "Editorial", "keywords": [{"value": "Editorials", "name": "subject", "is_major": "Y", "rank": "5"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "Malaria", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Vaccination and Immunization", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Gates, Bill and Melinda, Foundation", "name": "organizations", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "Editorial"}